Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily By: NewMediaWire May 30, 2023 at 07:30 AM EDT CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment NEW YORK, NY - (NewMediaWire) - May 30, 2023 - BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company focused on targeted immunotherapies for cancer, is pleased to announce that its President and CEO, William V. Williams, recently conducted an interview with SmallCapsDaily. During the interview, Mr. Williams discussed BriaCell's exciting and recent collaboration with Prevail Partners and Prevail Infoworks, as well as the Company's innovative strategy for cancer treatment.To read the full interview visit: https://smallcapsdaily.com/interview-briacell-ceo-william-williams-mdAbout BriaCell Therapeutics Corp.BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.More information is available at https://briacell.com/.For more information, please contact:Small Caps Dailyinfo@smallcapsdaily.comView the original release on www.newmediawire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily By: NewMediaWire May 30, 2023 at 07:30 AM EDT CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment NEW YORK, NY - (NewMediaWire) - May 30, 2023 - BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company focused on targeted immunotherapies for cancer, is pleased to announce that its President and CEO, William V. Williams, recently conducted an interview with SmallCapsDaily. During the interview, Mr. Williams discussed BriaCell's exciting and recent collaboration with Prevail Partners and Prevail Infoworks, as well as the Company's innovative strategy for cancer treatment.To read the full interview visit: https://smallcapsdaily.com/interview-briacell-ceo-william-williams-mdAbout BriaCell Therapeutics Corp.BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.More information is available at https://briacell.com/.For more information, please contact:Small Caps Dailyinfo@smallcapsdaily.comView the original release on www.newmediawire.com
CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment NEW YORK, NY - (NewMediaWire) - May 30, 2023 - BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company focused on targeted immunotherapies for cancer, is pleased to announce that its President and CEO, William V. Williams, recently conducted an interview with SmallCapsDaily. During the interview, Mr. Williams discussed BriaCell's exciting and recent collaboration with Prevail Partners and Prevail Infoworks, as well as the Company's innovative strategy for cancer treatment.To read the full interview visit: https://smallcapsdaily.com/interview-briacell-ceo-william-williams-mdAbout BriaCell Therapeutics Corp.BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.More information is available at https://briacell.com/.For more information, please contact:Small Caps Dailyinfo@smallcapsdaily.comView the original release on www.newmediawire.com